Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2021
Zydus and CHEMI sign license and supply agreement for enoxaparin injection
Zydus Pharmaceuticals Inc. signed a license and supply agreement with CHEMI SpA for the generic equivalent of Lovenox in seven dosage strengths in the United States. CHEMI will manufacture and supply the injection, and Zydus will commercialize it in the US.